Phesgo bnf
WebThe most common side effects of PHESGO when given with docetaxel for treatment of breast cancer that has spread to other parts of the body (metastatic) are: Diarrhea Hair loss Low levels of white blood cells with or without fever Nausea Feeling tired Rash Damage to the nerves (numbness, tingling, pain in hands/feet) WebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body …
Phesgo bnf
Did you know?
WebPHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive).
WebPertuzumab/trastuzumab (Phesgo®) provides a combination injection for subcutaneous use. Pertuzumab has previously been accepted by SMC under the orphan medicine process. This advice applies only in the context of an approved NHSScotland Patient Access Scheme (PAS) arrangement delivering the cost-effectiveness results upon which the decision ... WebPHESGO administration can result in subclinical and clinical cardiac failure. The incidence and severity was highest in patients receiving PHESGO with anthracycline-containing …
WebPertuzumab/trastuzumab (Phesgo®) used in combination with chemotherapy for the treatment of adults with HER2-positive early stage breast cancer or in combination with … WebJun 29, 2024 · FDA Approves Genentech’s Phesgo (Fixed-Dose Combination of Perjeta and Herceptin for Subcutaneous Injection) for HER2-Positive Breast Cancer Phesgo offers faster administration of Perjeta and Herceptin under the skin in just minutes, compared to hours with standard intravenous administration
WebSep 30, 2024 · A combination of trastuzumab and pertuzumab given as an injection under the skin (PHESGO) Hormonal (endocrine) Treatment Detailed Description: The research study procedures include screening for eligibility and study treatment including laboratory evaluations, physical exams, questionnaires, and follow up visits.
WebPHESGO ™ is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the … httpx redirectWebSolution for injection There can be variation in the licensing of different medicines containing the same drug. Solution for injection All products Excipients May contain … hoffman chevrolet hagerstown marylandWebPhesgo ® pertuzumab, trastuzumab, and hyaluronidase-zzxf Full Prescribing Information Safety Data Sheets (2 SDS) Side Effect Reporting You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch . You may also report side effects to Genentech at (888) 835-2555. Support & Resources httpx redirected urlWebTrade Name (s): Phesgo ® Pertuzumab/trastuzumab/hyaluronidase is the generic name for the trade name drug Phesgo. In some cases, health care professionals may use trade name or the generic name when referring to the drug. Drug Type: Pertuzumab, trastuzumab, and hyaluronidase is a targeted therapy. httpx readtimeoutWebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body … httpx read timeoutWebMar 1, 2024 · PHESGO may cause heart problems, including those without symptoms (such as reduced heart function) and those with symptoms (such as congestive heart failure). Your health professional may run tests to monitor your heart function before and during treatment with PHESGO. Based on test results your doctor may hold or discontinue treatment with … httpx-staticWebSign up today to receive the latest news and updates from UpToDate. Sign Up httpx library